Literature DB >> 16906012

Suffering in silence: why a developmental psychopathology perspective on selective mutism is needed.

Sharon L Cohan1, Joseph M Price, Murray B Stein.   

Abstract

A developmental psychopathology perspective is offered in an effort to organize the existing literature regarding the etiology of selective mutism (SM), a relatively rare disorder in which a child consistently fails to speak in 1 or more social settings (e.g., school) despite speaking normally in other settings (e.g., home). Following a brief description of the history, prevalence, and course of the disorder, multiple pathways to the development of SM are discussed, with a focus on the various genetic, temperamental, psychological, and social/environmental systems that may be important in conceptualizing this unusual childhood disorder. The authors propose that SM develops due to a series of complex interactions among the various systems reviewed (e.g., a strong genetic loading for anxiety interacts with an existing communication disorder, resulting in heightened sensitivity to verbal interactions and mutism in some settings). Suggestions are provided for future longitudinal, twin/adoption, molecular genetic, and neuroimaging studies that would be particularly helpful in testing the pathways perspective on SM.

Entities:  

Mesh:

Year:  2006        PMID: 16906012     DOI: 10.1097/00004703-200608000-00011

Source DB:  PubMed          Journal:  J Dev Behav Pediatr        ISSN: 0196-206X            Impact factor:   2.225


  16 in total

Review 1.  Children Who are Anxious in Silence: A Review on Selective Mutism, the New Anxiety Disorder in DSM-5.

Authors:  Peter Muris; Thomas H Ollendick
Journal:  Clin Child Fam Psychol Rev       Date:  2015-06

2.  A Two-Session Hierarchy for Shaping Successive Approximations of Speech in Selective Mutism: Pilot Study of Mobile Apps and Mechanisms of Behavior Change.

Authors:  Brian E Bunnell; Franklin Mesa; Deborah C Beidel
Journal:  Behav Ther       Date:  2018-02-16

Review 3.  Assessment and treatment of anxiety disorders in children and adolescents.

Authors:  Sucheta D Connolly; Liza Suarez; Carrie Sylvester
Journal:  Curr Psychiatry Rep       Date:  2011-04       Impact factor: 5.285

4.  A common genetic variant in the neurexin superfamily member CNTNAP2 is associated with increased risk for selective mutism and social anxiety-related traits.

Authors:  Murray B Stein; Bao-Zhu Yang; Denise A Chavira; Carla A Hitchcock; Sharon C Sung; Elisa Shipon-Blum; Joel Gelernter
Journal:  Biol Psychiatry       Date:  2010-12-30       Impact factor: 13.382

Review 5.  Selective mutism: an update and suggestions for future research.

Authors:  Samantha Scott; Deborah C Beidel
Journal:  Curr Psychiatry Rep       Date:  2011-08       Impact factor: 5.285

6.  Refining the classification of children with selective mutism: a latent profile analysis.

Authors:  Sharon L Cohan; Denise A Chavira; Elisa Shipon-Blum; Carla Hitchcock; Scott C Roesch; Murray B Stein
Journal:  J Clin Child Adolesc Psychol       Date:  2008-10

7.  Comparison of behavioral profiles for anxiety-related comorbidities including ADHD and selective mutism in children.

Authors:  Tal Levin-Decanini; Sucheta D Connolly; David Simpson; Liza Suarez; Suma Jacob
Journal:  Depress Anxiety       Date:  2013-03-22       Impact factor: 6.505

8.  Selective mutism and temperament: the silence and behavioral inhibition to the unfamiliar.

Authors:  Angelika Gensthaler; Sally Khalaf; Marc Ligges; Michael Kaess; Christine M Freitag; Christina Schwenck
Journal:  Eur Child Adolesc Psychiatry       Date:  2016-03-12       Impact factor: 4.785

Review 9.  'More than 100 years of silence', elective mutism: a review of the literature.

Authors:  Louise Sharkey; Fiona McNicholas
Journal:  Eur Child Adolesc Psychiatry       Date:  2008-03-20       Impact factor: 4.785

10.  Latent Class Symptom Profiles of Selective Mutism: Identification and Linkage to Temperamental and Social Constructs.

Authors:  Rachele Diliberto; Christopher A Kearney
Journal:  Child Psychiatry Hum Dev       Date:  2018-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.